These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 33233503)

  • 41. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii.
    Bafutto M; Almeida JR; Leite NV; Costa MB; Oliveira EC; Resende-Filho J
    Arq Gastroenterol; 2013; 50(4):304-9. PubMed ID: 24474234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
    Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
    Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice.
    Jiang W; Li M; He F; Zhou S; Zhu L
    J Neuroinflammation; 2017 Oct; 14(1):207. PubMed ID: 29070054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting the NLRP3 Inflammasome to Reduce Diet-Induced Metabolic Abnormalities in Mice.
    Chiazza F; Couturier-Maillard A; Benetti E; Mastrocola R; Nigro D; Cutrin JC; Serpe L; Aragno M; Fantozzi R; Ryffel B; Thiemermann C; Collino M
    Mol Med; 2016 Mar; 21(1):1025-1037. PubMed ID: 26623925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of NLRP3 inflammasome attenuates spinal cord injury-induced lung injury in mice.
    Jiang W; Li M; He F; Zhu L
    J Cell Physiol; 2019 May; 234(5):6012-6022. PubMed ID: 30589073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.
    Yu ZC; Cen YX; Wu BH; Wei C; Xiong F; Li DF; Liu TT; Luo MH; Guo LL; Li YX; Wang LS; Wang JY; Yao J
    World J Gastroenterol; 2019 Aug; 25(29):3956-3971. PubMed ID: 31413530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [An investigation of signal transduction pathway of colonic mucosal toll-like receptor 4 in patients with diarrhea-irritable bowel syndrome].
    Wang XM; Liu YL
    Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):491-4. PubMed ID: 20979736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Curcumin Represses NLRP3 Inflammasome Activation via TLR4/MyD88/NF-κB and P2X7R Signaling in PMA-Induced Macrophages.
    Kong F; Ye B; Cao J; Cai X; Lin L; Huang S; Huang W; Huang Z
    Front Pharmacol; 2016; 7():369. PubMed ID: 27777559
    [No Abstract]   [Full Text] [Related]  

  • 51. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
    Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
    World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis.
    Zhong W; Lu X; Shi H; Zhao G; Song Y; Wang Y; Zhang J; Jin Y; Wang S
    J Clin Gastroenterol; 2019 Oct; 53(9):660-672. PubMed ID: 29210899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Similar Fecal Microbiota Signatures in Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Patients With Depression.
    Liu Y; Zhang L; Wang X; Wang Z; Zhang J; Jiang R; Wang X; Wang K; Liu Z; Xia Z; Xu Z; Nie Y; Lv X; Wu X; Zhu H; Duan L
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1602-1611.e5. PubMed ID: 27266978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The dietary features of diarrhea predominant irritable bowel syndrome patients with small intestinal bowel overgrowth].
    Wei H; Liu ZJ; Wang K; Zheng W; Duan LP
    Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):567-571. PubMed ID: 28789488
    [No Abstract]   [Full Text] [Related]  

  • 56. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
    Kong WM; Gong J; Dong L; Xu JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1345-7. PubMed ID: 17884774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.
    Hod K; Sperber AD; Ron Y; Boaz M; Dickman R; Berliner S; Halpern Z; Maharshak N; Dekel R
    Neurogastroenterol Motil; 2017 Jul; 29(7):. PubMed ID: 28271623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome.
    Jacenik D; Cygankiewicz AI; Fichna J; Mokrowiecka A; Małecka-Panas E; Krajewska WM
    Mol Cell Endocrinol; 2018 Aug; 471():89-96. PubMed ID: 28774781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
    Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes.
    Kong F; Ye B; Lin L; Cai X; Huang W; Huang Z
    Biomed Pharmacother; 2016 Aug; 82():167-72. PubMed ID: 27470352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.